Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Addictive Behaviors|April 2, 2021
Trends in frequency of e-cigarette use among cancer patients and survivors in the United States, 2014-2018Elena O Dewar, Edward Christopher Dee, Melaku A Arega, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Obesity and younger versus older onset colorectal cancer in the United States, 1998-2017Nina N Sanford, Edward L Giovannucci, Chul Ahn, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Screening Implications for Distribution of Colorectal Cancer Subsite by AgeGloria Lin, David M Hein, Po-Hong Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2022
Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger AdultsPo-Hong Liu, Nina N Sanford, Peter S Liang, et al.
Journal of Wound Care|September 30, 2016
Microbiota is a primary cause of pathogenesis of chronic woundsR Wolcott, N Sanford, R Gabrilska, et al.
Blood|October 4, 2003
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndromeLisa M Piliero, Amy N Sanford, Donna M McDonald-McGinn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2018
Sex Disparity and Copy Number Alterations in Esophageal Squamous Cell CarcinomaNina N Sanford, Brandon A Mahal, Trevor J Royce, et al.
Advances in Radiation Oncology|April 21, 2026
Global Assessment of Megavoltage External Beam Radiation Therapy Facilities: Current Status and Projections for 2030-2050Fatemeh Sadat Tabatabaei, Amirali Azimi, Romina Abyaneh, et al.
Oral Oncology|November 10, 2018
HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynxLuke R G Pike, William L Hwang, Trevor J Royce, et al.
Prostate Cancer and Prostatic Diseases|November 9, 2016
Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of deathN N Sanford, M-H Chen, M Loffredo, et al.
Pageof 11